Assessment of DHA on Reducing Early Preterm Birth

Assessment of DHA On Reducing Early Preterm Birth

The purpose of this study is to determine if giving a larger amount of DHA than currently included in some prenatal supplements can reduce early preterm birth (birth before 34 weeks of pregnancy).

Pharmaceutical medication involved
Patients and healthy individuals accepted

Drug - Docosahexaenoic acid - 800mg/day

All participants will take 1000 mg/DHA per day (1 capsule will be labeled with 200 mg; 2 capsules will be masked with 400 mg each)

Drug - Docosahexaenoic acid - 200mg/day

The control group will receive 1-capsule containing 200 mg DHA/d.


Participants will receive 2 capsules (masked) containing half soybean oil and half corn oil equaling 800 mg.The soybean and corn oil combination does not contain DHA.

Assessment of DHA On Reducing Early Preterm Birth (ADORE Trial)